The Effect of Tetanus-Diphtheria-Acellular-Pertussis Immunization During Pregnancy on Infant Antibody Responses:

Bahaa Abu-Raya1,2, Kirsten Maertens3, Flor M Munoz4

  • 1Vaccine Evaluation Center, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada.

Insights

Maternal tetanus-diphtheria-acellular pertussis (Tdap) vaccination in pregnancy leads to lower infant antibody responses to pertussis and diphtheria. Enhanced surveillance for these diseases in infants is recommended.

Area of Science:

  • Immunology
  • Vaccinology
  • Maternal and Child Health

Background:

  • Maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine during pregnancy is increasingly recommended.
  • The impact of maternal Tdap vaccination on infant immune responses to routine childhood immunizations requires thorough investigation.

Purpose of the Study:

  • To determine the effect of maternal Tdap immunization during pregnancy on infants' antibody responses to routine vaccines.
  • To compare antibody levels and seroprotection rates in infants born to Tdap-immunized mothers versus unimmunized mothers.

Main Methods:

  • An individual-participant data meta-analysis was conducted, pooling data from ten studies with 1884 participants.
  • Infants' antigen-specific immunoglobulin G (IgG) levels and seroprotection rates were analyzed using mixed-effects models and chi-squared tests.

Main Results:

  • Infants of Tdap-immunized mothers showed significantly lower IgG levels against pertussis components (pertussis toxin, FHA, pertactin, FIM2/3) and diphtheria after primary immunization.
  • Lower antibody levels persisted for some pertussis antigens after booster immunization.
  • Infants of Tdap-immunized mothers had lower seroprotection rates against diphtheria and certain *Streptococcus pneumoniae* (SPN) serotypes, but higher rates against *Haemophilus influenzae* type b.

Conclusions:

  • Maternal Tdap vaccination in pregnancy is associated with reduced infant antibody responses to pertussis, diphtheria, and some SPN serotypes.
  • Clinical significance necessitates enhanced surveillance of pertussis, diphtheria, and invasive pneumococcal disease (IPD) in infants born to vaccinated mothers.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
533
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.3K
Vaccinations01:51

Vaccinations

Overview
47.3K
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
7.5K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.2K